Vanguard Group Inc Exagen Inc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Exagen Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 490,944 shares of XGN stock, worth $1.65 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
490,944
Previous 490,944
-0.0%
Holding current value
$1.65 Million
Previous $1.52 Million
32.63%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding XGN
# of Institutions
43Shares Held
6.05MCall Options Held
1.1KPut Options Held
6.4K-
Rtw Investments, LP New York, NY1.51MShares$5.08 Million0.1% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A6891KShares$2.99 Million0.01% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY535KShares$1.8 Million0.02% of portfolio
-
Morgan Stanley New York, NY484KShares$1.63 Million0.0% of portfolio
-
Perkins Capital Management Inc424KShares$1.42 Million1.67% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $54.6M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...